ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 121 filers reported holding ANI PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.17 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,658,310 | +31.4% | 321,321 | +21.9% | 0.00% | 0.0% |
| Q2 2023 | $14,195,024 | +45.8% | 263,701 | +7.6% | 0.00% | +100.0% |
| Q1 2023 | $9,735,570 | +101006.8% | 245,105 | +2.4% | 0.00% | 0.0% |
| Q4 2022 | $9,629 | -99.9% | 239,349 | +4.6% | 0.00% | 0.0% |
| Q3 2022 | $7,353,000 | +6.9% | 228,792 | -1.3% | 0.00% | 0.0% |
| Q2 2022 | $6,878,000 | +24.9% | 231,845 | +18.3% | 0.00% | 0.0% |
| Q1 2022 | $5,507,000 | -41.3% | 195,916 | -3.7% | 0.00% | 0.0% |
| Q4 2021 | $9,375,000 | +75.2% | 203,453 | +24.8% | 0.00% | 0.0% |
| Q3 2021 | $5,350,000 | -12.0% | 163,037 | -6.0% | 0.00% | 0.0% |
| Q2 2021 | $6,078,000 | +5.1% | 173,422 | +8.4% | 0.00% | 0.0% |
| Q1 2021 | $5,782,000 | +41.8% | 160,014 | +14.0% | 0.00% | 0.0% |
| Q4 2020 | $4,077,000 | -0.3% | 140,414 | -3.2% | 0.00% | 0.0% |
| Q3 2020 | $4,090,000 | -9.7% | 145,000 | +3.5% | 0.00% | 0.0% |
| Q2 2020 | $4,531,000 | -18.4% | 140,132 | +2.8% | 0.00% | 0.0% |
| Q1 2020 | $5,551,000 | -64.0% | 136,276 | -45.5% | 0.00% | -50.0% |
| Q4 2019 | $15,406,000 | +81.0% | 249,844 | +113.9% | 0.00% | 0.0% |
| Q3 2019 | $8,512,000 | -10.7% | 116,797 | +0.7% | 0.00% | 0.0% |
| Q2 2019 | $9,535,000 | +27.6% | 116,013 | +9.5% | 0.00% | 0.0% |
| Q1 2019 | $7,473,000 | -14.8% | 105,961 | -45.6% | 0.00% | +100.0% |
| Q4 2018 | $8,774,000 | +64.0% | 194,918 | +106.0% | 0.00% | -50.0% |
| Q3 2018 | $5,350,000 | -8.3% | 94,632 | +8.4% | 0.00% | 0.0% |
| Q2 2018 | $5,833,000 | +20.3% | 87,334 | +4.8% | 0.00% | 0.0% |
| Q1 2018 | $4,850,000 | -2.2% | 83,310 | +8.2% | 0.00% | 0.0% |
| Q4 2017 | $4,961,000 | +42.0% | 76,978 | +15.7% | 0.00% | +100.0% |
| Q3 2017 | $3,493,000 | +14.2% | 66,548 | +1.8% | 0.00% | 0.0% |
| Q2 2017 | $3,058,000 | -4.0% | 65,347 | +1.5% | 0.00% | 0.0% |
| Q1 2017 | $3,187,000 | -14.6% | 64,378 | +4.6% | 0.00% | -50.0% |
| Q4 2016 | $3,731,000 | +1.1% | 61,562 | +10.7% | 0.00% | 0.0% |
| Q3 2016 | $3,689,000 | +20.5% | 55,612 | +1.4% | 0.00% | 0.0% |
| Q2 2016 | $3,061,000 | +70.9% | 54,845 | +3.1% | 0.00% | +100.0% |
| Q1 2016 | $1,791,000 | -24.7% | 53,221 | +1.0% | 0.00% | 0.0% |
| Q4 2015 | $2,377,000 | +14.3% | 52,678 | +0.1% | 0.00% | 0.0% |
| Q3 2015 | $2,079,000 | -34.3% | 52,648 | +3.2% | 0.00% | -50.0% |
| Q2 2015 | $3,164,000 | +3.1% | 51,003 | +3.9% | 0.00% | 0.0% |
| Q1 2015 | $3,069,000 | +16.6% | 49,080 | +5.1% | 0.00% | 0.0% |
| Q4 2014 | $2,632,000 | +155.3% | 46,678 | +28.0% | 0.00% | +100.0% |
| Q3 2014 | $1,031,000 | -15.1% | 36,462 | +3.3% | 0.00% | 0.0% |
| Q2 2014 | $1,215,000 | +27.5% | 35,299 | +16.0% | 0.00% | 0.0% |
| Q1 2014 | $953,000 | +58.6% | 30,423 | +1.5% | 0.00% | – |
| Q4 2013 | $601,000 | +113.9% | 29,980 | +4.2% | 0.00% | – |
| Q3 2013 | $281,000 | – | 28,784 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 272,801 | $15,838,826 | 7.50% |
| Global Alpha Capital Management Ltd. | 525,528 | $30,512,156 | 3.06% |
| Rubric Capital Management LP | 847,011 | $49,177,459 | 1.84% |
| Ranger Investment Management | 426,848 | $24,782,795 | 1.64% |
| Parkman Healthcare Partners LLC | 111,802 | $6,491,224 | 1.19% |
| MARATHON CAPITAL MANAGEMENT | 71,670 | $4,161,160 | 1.05% |
| Mesirow Financial Investment Management, Inc. | 3,862 | $224,228 | 0.98% |
| Deep Track Capital, LP | 400,000 | $23,224,000 | 0.90% |
| 1492 Capital Management LLC | 18,178 | $1,055,415 | 0.68% |
| Phocas Financial Corp. | 75,213 | $4,367,000 | 0.64% |